MIT Technology Review September 29, 2023
Cassandra Willyard

Artificial wombs are nearing human trials. But the goal is to save the littlest preemies, not replace the uterus.

On September 19, US Food and Drug Administration advisors met to discuss how to move research on artificial wombs from animals into humans. These medical devices are designed to give extremely premature infants a bit more time to develop in a womblike environment before entering the outside world. They have been tested with hundreds of lambs (and some piglets), but animal models can’t fully predict how the technology will work for humans.

“The most challenging question to answer is how much unknown is...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: FDA, Govt Agencies, Medical Devices, Patient / Consumer, Provider
Olympus and Ziosoft partner to convert CT and MR scans into surgical 3D models
MicroTransponder secures $65 million to expand stroke recovery therapy
Who’s Leading the FDA’s AI Race? Top Medical Specialties and Companies to Watch
Dr. Oz stresses need for faster Medicare coverage of new devices during confirmation hearing
People Are Getting Brain Implants For BCI

Share This Article